Skip to main content

Tracking ARKG Genomic ETF 20250813

PRMEPrime Medicine Inc4,899,178.00-35.10%3,179,406.0012,113,536.863.4610.12%3.81
MASS908 Devices Inc246,056.0058.64%390,353.002,751,988.656.478.96%7.05
EXASExact Sciences Corp3,509,282.0050.08%5,266,810.00236,532,437.1041.747.59%44.91
VCYTVeracyte Inc1,403,699.0094.42%2,729,117.0083,729,309.5628.776.64%30.68
GHGuardant Health Inc1,903,198.0060.27%3,050,192.00178,649,745.4455.16.30%58.57
TXG10X Genomics Inc3,954,806.0094.23%7,681,342.00104,235,810.9412.815.93%13.57
PACBPacific Biosciences of California Inc10,642,017.00114.12%22,786,298.0029,166,461.441.215.79%1.28
WGSGeneDx Holdings Corp660,217.0039.10%918,346.00113,057,576.06116.415.76%123.11
PSNLPersonalis Inc1,125,347.0013.99%1,282,797.006,195,909.514.575.69%4.83
CAICaris Life Sciences Inc1,254,216.0046.10%1,832,420.0062,815,357.6032.465.61%34.28
NRIXNurix Therapeutics Inc610,421.00-10.90%543,887.005,748,885.5910.025.49%10.57
RXRXRecursion Pharmaceuticals Inc16,620,537.0040.76%23,394,831.00133,350,536.705.415.36%5.7
SDGRSchrodinger Inc1,134,970.0048.95%1,690,507.0033,539,658.8818.855.25%19.84
INCYIncyte Corp1,810,225.0073.85%3,147,140.00270,181,969.0081.615.20%85.85
ABSIAbsci Corp5,208,974.00158.86%13,483,740.0042,069,268.802.975.05%3.12
TEMTempus AI Inc15,619,115.0023.52%19,292,997.001,343,371,381.1166.344.96%69.63
TWSTTwist Bioscience Corp2,202,571.0068.73%3,716,336.00106,473,026.4027.454.37%28.65
IONSIonis Pharmaceuticals Inc1,496,847.00101.82%3,020,967.00130,203,677.7041.414.08%43.1
BEAMBeam Therapeutics Inc2,792,502.0028.60%3,591,105.0062,916,159.6016.863.91%17.52
ILMNIllumina Inc1,491,083.009.08%1,626,543.00164,459,762.7397.383.83%101.11
CERSCerus Corp1,348,790.00104.94%2,764,206.003,676,393.981.293.10%1.33
ADPTAdaptive Biotechnologies Corp1,987,056.0018.75%2,359,707.0030,676,191.0012.662.69%13
BFLYButterfly Network Inc2,522,891.0031.31%3,312,876.004,704,283.921.392.16%1.42
VRTXVertex Pharmaceuticals Inc2,044,598.00-6.46%1,912,617.00757,243,322.64387.772.10%395.92
CMPSCompass Pathways PLC1,608,395.0034.35%2,160,846.009,270,029.344.221.66%4.29
AMGNAmgen Inc2,200,356.00-18.88%1,785,036.00516,464,465.88284.981.53%289.33
VEEVVeeva Systems Inc1,268,004.00-34.76%827,219.00230,943,000.42275.431.36%279.18
CRSPCrispr Therapeutics AG2,181,047.00218.01%6,935,888.00397,634,459.0456.61.29%57.33
NTLAIntellia Therapeutics Inc4,030,043.00138.12%9,596,409.00105,560,499.0010.861.29%11
REGNRegeneron Pharmaceuticals Inc766,066.0043.02%1,095,641.00615,257,203.55556.550.90%561.55
QSIQuantum-Si Inc9,882,629.00-30.32%6,886,334.008,057,010.781.160.86%1.17
LABStandard Biotools Inc1,385,850.0045.46%2,015,899.002,640,827.691.310.00%1.31
NTRANatera Inc1,838,318.00-36.46%1,168,112.00184,211,262.40159.81-1.32%157.7
ATAIATAI Life Sciences NV5,325,560.00-17.81%4,377,338.0017,728,218.904.13-1.94%4.05
CDNACareDx Inc1,596,993.0012.09%1,790,040.0021,713,185.2012.46-2.65%12.13

Comments

Popular posts from this blog

Nebius Group Rocket after earning release

  After checking the earning and price action, share with you on this Nebius and check the right price for entry.  I will analyze Nebius Group N.V. (NBIS) and its peers using a framework inspired by Charlie Munger’s approach to investing, which emphasizes understanding a company’s competitive moat, management quality, financial health, and long-term growth potential while considering risks and market dynamics. I’ll incorporate insights from recent earnings, government policies, regulatory climate, labor conditions, suppliers, customers, competitive landscape, technological trends, vulnerabilities, pricing power, scalability, and financial performance to provide a comprehensive analysis and forecast for NBIS in 2025. The analysis will also benchmark NBIS against peers like CoreWeave and major hyperscalers (e.g., AWS, Microsoft Azure). ### Overview of Nebius Group N.V. (NBIS) Nebius Group N.V. is a Netherlands-based technology company specializing in AI infrastructure, offering ...

Sector Performance MTD review 20250829

  Based on the  data table showing Year-to-Date (YTD) performance and the latest one-month percentage changes for various ETFs as of August 31, 2025, here’s a summary: Code Name 20241231 1 month % +/- 20250131 1 month % +/- 202500228 1 month % +/- 20250331 1 month % +/- 20250430 1 month % +/- 25200530 1 month % +/- 20250630 1 month % +/- 20250731 1 month % +/- 2025829 YTD % +/- ETHA iShares Ethereum Trust ETF 25.29 -0.67% 25.12 -33.16% 16.79 -17.69% 13.82 1.01% 13.96 37.39% 19.18 -0.57% 19.07 48.24% 28.27 16.09% 32.82 29.77% UFO Procure Space ETF 23.22 5.86% 24.58 -4.27% 23.53 -6.20% 22.07 1.27% 22.35 9.04% 24.37 17.93% 28.74 3.20% 29.66 14.26% 33.89 45.95% ITB iShares US Home Construction ETF 103.39 3.73% 107.25 -7.84% 98.84 -3.67% 95.21 -3.51% 91.87 -3.67% 88.5 5.28% 93.17 4.55% 97.41 13.64% 110.7 7.07% TAN Invesco Solar ETF 33.12 2.05% 33.8 -4.29% 32.35 -5.84% 30.46 -5.45% 28.8 10.49% 31.82 7.67% 34.26 7.41% 36.8 12.91% 41.55 25.45% JETS US Global Jets ETF 25.35 2.68% 26.03...

Military Drone Company Study 05 AeroVironment Inc. (AVAV)

  # AeroVironment, Inc. (NASDAQ: AVAV) Fundamental Research Report ## Company Overview and Business Model **Business Model**: AeroVironment, Inc. (NASDAQ: AVAV) is a leading U.S. defense contractor specializing in uncrewed systems, tactical missile systems, and related technologies. The company designs, develops, and manufactures small to medium-sized unmanned aerial vehicles (UAVs or drones), loitering munitions (e.g., Switchblade), high-altitude pseudo-satellites, and advanced defense technologies, including counter-UAS (unmanned aerial systems), space-based platforms, directed energy systems, and cyber/electronic warfare capabilities. Following its acquisition of BlueHalo in fiscal year 2025, AeroVironment has expanded its portfolio to include space, cyber, and directed energy solutions, enhancing its capabilities across air, land, sea, space, and cyber domains.[](https://www.tradingview.com/news/tradingview:5371bff07f1d8:0-aerovironment-inc-sec-10-k-report/)[](https://www.tipra...